COVID-19 in the Central Nervous System - clinical manifestations and post-COVID syndrome - an update
DOI:
https://doi.org/10.12775/JEHS.2024.76.56397Keywords
COVID-19, Post Acute COVID 19 Syndrome, SARS-CoV-2 Virus, Neurological Manifestations, Central Nervous System Viral DiseasesAbstract
Introduction:
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a significant global public health challenge. While respiratory symptoms dominate, the virus's impact on other systems, particularly the central nervous system (CNS), has gained increasing attention. SARS-CoV-2 demonstrates tropism for Angiotensin-Converting Enzyme 2 (ACE2) receptors, expressed in the olfactory epithelium, lungs, endothelium, kidneys, enterocytes, and neurons, contributing to neurological manifestations observed during the acute phase of the disease.
Materials and Methods:
A literature review was conducted using PubMed, Scopus, Web of Science, and ScienceDirect databases. Keywords included: COVID-19, Post Acute COVID-19 Syndrome, SARS-CoV-2 Virus, Neurological Manifestations, and Central Nervous System Viral Diseases. A total of 58 articles were selected for analysis based on relevance and quality of evidence regarding neurological symptoms and complications associated with COVID-19.
Basic Results:
The acute phase of COVID-19 frequently involves neurological symptoms such as frontal and holocranial headaches, dizziness, gustatory and olfactory dysfunctions, and alterations in consciousness. Severe complications, though less common, include encephalitis, ischemic and hemorrhagic stroke, cerebral venous thrombosis, and myelitis. These conditions often present as altered mental status, seizures, aphasia, headaches, or focal deficits, contributing substantially to patient morbidity and mortality.
Conclusions:
Neurological symptoms and complications constitute a significant aspect of COVID-19, highlighting the virus's potential to affect the CNS. While severe complications are rare, their profound impact on prognosis underscores the importance of early recognition and management. Further research is essential to understand the pathophysiology and optimise therapeutic approaches for affected patients.
References
World Health Organization. Statement on the Fifteenth Meeting of the IHR ( 2005 ) Emergency Committee on the COVID-19 Pandemic. World Heal Organ; 2023 [online] https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic [accessed on January 8, 2024].
Renu K., Prasanna PL., Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review. Life Sci. 2020; 255: 1-15, doi: 10.1016/j.lfs.2020.117839.
Mao L., Jin H., Wang M., Hu Y., Chen S., He Q. et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6): 683-690, doi: 10.1001/jamaneurol.2020.1127.
Ousseiran Z.H., Fares Y., Chamoun W.T. Neurological manifestations of COVID-19: a systematic review and detailed comprehension. Int J Neurosci. 2023; 133(7): 754-769, doi: 10.1080/00207454.2021.1973000.
Dos Anjos de Paula R. C., de Maria Frota Vasconcelos T., da Costa F. B. S., de Brito L. A., Torres D. M., Moura A. E. F. et al. Characterization of Headache in COVID-19: a Retrospective Multicenter Study. Mol Neurobiol. 2021; 58(9): 4487-4494, doi: 10.1007/s12035-021-02430-w.
Trigo J., García-Azorín D., Planchuelo-Gómez Á., Martínez-Pías E., Talavera B., Hernández-Pérez I. et al. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. J Headache Pain. 2020; 21(1): 1-10, doi: 10.1186/s10194-020-01165-8.
Caronna E., Ballvé A., Llauradó A., Gallardo V. J., Ariton D. M., Lallana S. et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020; 40(13): 1410-1421, doi: 10.1177/0333102420965157.
Thepmankorn P., Bach J., Lasfar A., Zhao X., Souayah S., Chong Z. Z. et al. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations. Cytokine. 2021; 138: 2-10, doi: 10.1016/j.cyto.2020.155404.
Korres G., Kitsos D. K., Kaski D., Tsogka A., Giannopoulos S., Giannopapas V. et al. The Prevalence of Dizziness and Vertigo in COVID-19 Patients: A Systematic Review. Brain Sci. 2022; 12(7): 948, doi: 10.3390/brainsci12070948.
Jafari Z., Kolb B.E., Mohajerani M.H. Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis. Can J Neurol Sci. 2022; 49(2): 184-195, doi: 10.1017/cjn.2021.63.
Viola P., Ralli M., Pisani D., Malanga D., Sculco D., Messina L. et al. Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Otorhinolaryngol. 2021; 278(10): 3725-3730, doi: 10.1007/s00405-020-06440-7.
Saniasiaya J., Islam M.A., Abdullah B. Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients. Laryngoscope. 2021; 131(4): 865-878, doi: 10.1002/lary.29286.
Berlit P., Bösel J., Gahn G., Isenmann S., Meuth S. G., Nolte C. H. et al. "Neurological manifestations of COVID-19" - guideline of the German society of neurology. Neurol Res Pract. 2020; 2(1): 2-10, doi: 10.1186/s42466-020-00097-7.
Brann D.H., Tsukahara T., Weinreb C., Lipovsek M., Van den Berge K., Gong B. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020; 6(31): 1-15, doi: 10.1126/sciadv.abc5801.
Tong J.Y., Wong A., Zhu D., Fastenberg J.H., Tham T. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2020; 163(1): 3-11, doi: 10.1177/0194599820926473.
Pennisi M., Lanza G., Falzone L., Fisicaro F., Ferri R., Bella R. SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms. Int J Mol Sci. 2020; 21(15): 5475, doi: 10.3390/ijms21155475.
Pezzini A., Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020; 16(11): 636-644, doi: 10.1038/s41582-020-0398-3.
Scoppettuolo P., Borrelli S., Naeije G. Neurological involvement in SARS-CoV-2 infection: A clinical systematic review. Brain Behav Immun Health. 2020; 5: 1-8, doi: 10.1016/j.bbih.2020.100094.
Rifino N., Censori B., Agazzi E., Alimonti D., Bonito V., Camera G. et al. Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy. J Neurol. 2021; 268(7): 2331-2338, doi: 10.1007/s00415-020-10251-5.
Siow I., Lee K.S., Zhang J.J.Y., Saffari S.E., Ng A. Encephalitis as a neurological complication of COVID-19: A systematic review and meta-analysis of incidence, outcomes, and predictors. Eur J Neurol. 2021; 28(10): 3491-3502, doi: 10.1111/ene.14913.
Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q. et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022; 9(10): 815-827, doi: 10.1016/S2215-0366(22)00260-7.
Baud D., Qi X., Nielsen-Saines K., Musso D., Pomar L., Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020; 20(7): 773, doi: 10.1016/S1473-3099(20)30195-X.
Nikbakht F., Mohammadkhanizadeh A., Mohammadi E. How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms. Mult Scler Relat Disord. 2020; 46:102535, doi: 10.1016/j.msard.2020.102535.
Carroll E., Melmed K. R., Frontera J., Placantonakis D. G., Galetta S., Balcer L. et al. Cerebrospinal fluid findings in patients with seizure in the setting of COVID-19: A review of the literature. Seizure. 2021; 89: 99-106, doi: 10.1016/j.seizure.2021.05.003.
Liotta E. M., Batra A., Clark J. R., Shlobin N. A., Hoffman S. C., Orban Z. S. et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020; 7(11): 2221-2230, doi: 10.1002/acn3.51210.
Shamim D., Ganatra F., Khan M., Gronseth G. New Onset Seizures in Hospitalized COVID-19 Patients; A Systematic Review and Meta-Analysis. Neurohospitalist. 2024; 14(1): 34-43, doi: 10.1177/19418744231202317.
Mondal R., Deb S., Shome G., Ganguly U., Lahiri D., Benito-León J. COVID-19 and emerging spinal cord complications: A systematic review. Mult Scler Relat Disord. 2021; 51: 1-9, doi: 10.1016/j.msard.2021.102917.
Garg R.K., Paliwal V.K., Gupta A. Spinal cord involvement in COVID-19: A review. J Spinal Cord Med. 2023; 46(3): 390-404, doi:10.1080/10790268.2021.1888022.
Ismail I.I., Salama S. Association of CNS demyelination and COVID-19 infection: an updated systematic review. J Neurol. 2022; 269(2): 541-576, doi: 10.1007/s00415-021-10752-x.
Kummer B.R., Klang E., Stein L.K., Dhamoon M.S., Jetté N. History of Stroke Is Independently Associated with In-Hospital Death in Patients With COVID-19. Stroke. 2020; 51(10): 3112-3114, doi: 10.1161/STROKEAHA.120.030685.
Tsivgoulis G., Palaiodimou L., Zand R., Lioutas V. A., Krogias C., Katsanos A. H. et al. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord. 2020; 13: 1-18, doi: 10.1177/1756286420978004.
Tan Y. K., Goh C., Leow A. S. T., Tambyah P. A., Ang A., Yap E. S. et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020; 50(3): 587-595, doi: 10.1007/s11239-020-02228-y.
Ntaios G., Michel P., Georgiopoulos G., Guo Y., Li W., Xiong J. et al. Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry. Stroke. 2020; 51(9): 254-258, doi: 10.1161/STROKEAHA.120.031208.
Ramos-Araque M. E., Siegler J. E., Ribo M., Requena M., López C., de Lera M. et al. Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry. BMC Neurol. 2021; 21(1): 1-11, doi: 10.1186/s12883-021-02075-1.
Kvernland A., Kumar A., Yaghi S., Raz E., Frontera J., Lewis A. et al. Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System. Neurocrit Care. 2021; 34(3): 748-759, doi: 10.1007/s12028-020-01077-0.
Leasure A. C., Khan Y. M., Iyer R., Elkind M. S. V., Sansing L. H., Falcone G. J. et al. Intracerebral Hemorrhage in Patients With COVID-19: An Analysis From the COVID-19 Cardiovascular Disease Registry. Stroke. 2021; 52(7): 321-323, doi: 10.1161/STROKEAHA.121.034215.
Dogra S., Jain R., Cao M., Bilaloglu S., Zagzag D., Hochman S. et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis. 2020; 29(8): 1-6, doi: 10.1016/j.jstrokecerebrovasdis.2020.104984.
Tu T. M., Goh C., Tan Y. K., Leow A. S., Pang Y. Z., Chien J. et al. Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review. J Stroke Cerebrovasc Dis. 2020; 29(12): 1-9, doi: 10.1016/j.jstrokecerebrovasdis.2020.105379.
Li Y., Li M., Wang M., Zhou Y., Chang J., Xian Y. et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020; 5(3): 279-284, doi: 10.1136/svn-2020-000431.
Hameed S., Wasay M., Soomro B. A., Mansour O., Abd-Allah F., Tu T. et al. Cerebral Venous Thrombosis Associated with COVID-19 Infection: An Observational, Multicenter Study. Cerebrovasc Dis Extra. 2021; 11(2): 55-60, doi: 10.1159/000516641.
Baldini T., Asioli G. M., Romoli M., Carvalho Dias M., Schulte E. C., Hauer L. et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis. Eur J Neurol. 2021; 28(10): 3478-3490, doi: 10.1111/ene.14727.
Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8(5): 416-427, doi: 10.1016/S2215-0366(21)00084-5.
Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021; 374: 1-18, doi: 10.1136/bmj.n1648.
Nikitina A.Y., Chimagomedova A.S., Levin O.S. Neurological Complications of COVID-19 in the Elderly. Neurosci Behav Physiol. 2022; 52(5): 625-634, doi: 10.1007/s11055-022-01287-3.
Sampaio Rocha-Filho P.A. Headache associated with COVID-19: Epidemiology, characteristics, pathophysiology, and management. Headache. 2022; 62(6): 650-656, doi: 10.1111/head.14319.
García-Azorín D., Sierra Á., Trigo J., Alberdi A., Blanco M., Calcerrada I. et al. Frequency and phenotype of headache in covid-19: a study of 2194 patients. Sci Rep. 2021; 11(1): 1-10, doi: 10.1038/s41598-021-94220-6.
Garcia-Azorin D., Layos-Romero A., Porta-Etessam J., Membrilla J. A., Caronna E., Gonzalez-Martinez A. et al. Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients. Cephalalgia. 2022; 42(8): 804-809, doi: 10.1177/03331024211068074.
Uygun Ö., Ertaş M., Ekizoğlu E., Bolay H., Özge A., Kocasoy Orhan E. et al. Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain. 2020; 21(1): 1-10, doi: 10.1186/s10194-020-01188-1.
Pendergrast T., Brown A., Sunnquist M., Jantke R., Newton J. L., Strand E. B. et al. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. 2016; 12(4): 292-307, doi: 10.1177/1742395316644770.
Islam M.F., Cotler J., Jason L.A. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue. 2020; 8(2): 1-9, doi: 10.1080/21641846.2020.1778227.
Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011; 11: 1-7, doi: 10.1186/1471-2377-11-37.
Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come?. Med Hypotheses. 2021; 146: 1-5, doi: 10.1016/j.mehy.2020.110469.
Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P. A., Cuapio A. et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Reports. 2021; 11(1): 1-22, doi: 10.1101/2021.01.27.21250617.
Salari N., Khodayari Y., Hosseinian-Far A., Zarei H., Rasoulpoor S., Akbari H. et al. Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis. Biopsychosoc Med. 2022; 16(1): 1-12, doi: 10.1186/s13030-022-00250-5.
Seeßle J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A. et al. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin Infect Dis. 2022; 74(7): 1191-1198, doi: 10.1093/cid/ciab611.
Hill E., Mehta H., Sharma S., Mane K., Xie C., Cathey E. et al. Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as part of the NIH RECOVER program. medRxiv. 2022; 2022.08.15.22278603: 1-30, doi: 10.1101/2022.08.15.22278603.
Graham E. L., Clark J. R., Orban Z. S., Lim P. H., Szymanski A. L., Taylor C. et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021; 8(5): 1073-1085, doi: 10.1002/acn3.51350.
Takao M., Ohira M. Neurological post-acute sequelae of SARS-CoV-2 infection. Psychiatry Clin Neurosci. 2023; 77(2): 72-83, doi:10.1111/pcn.13481.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aleksandra Śmigiel, Zuzanna Mularczyk, Piotr Oleksy, Magdalena Reclik, Ewa Góralczyk, Michalina Rzepka, Joanna Siuda
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 93
Number of citations: 0
